Harmony Biosciences Holdings, Inc. HRMY Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.
The official record: Harmony Biosciences Holdings, Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s free cash flow?
- Harmony Biosciences Holdings, Inc. (HRMY) reported free cash flow of $126.04M in Q4 2025.
- How has Harmony Biosciences Holdings, Inc.'s free cash flow changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s free cash flow increased by 67.9% year-over-year, from $75.05M to $126.04M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s free cash flow?
- Over 3 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s free cash flow has grown at a 52.4% compound annual growth rate (CAGR), from $98.26M to $347.89M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.